{"id":2603,"date":"2024-05-22T20:41:54","date_gmt":"2024-05-22T13:41:54","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=2603"},"modified":"2024-05-22T20:41:54","modified_gmt":"2024-05-22T13:41:54","slug":"i-mab-to-participate-at-the-jefferies-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=2603","title":{"rendered":"I-Mab to Participate at the Jefferies Global Healthcare Conference"},"content":{"rendered":"

ROCKVILLE, Md.<\/span><\/span>, May 22, 2024<\/span><\/span> \/PRNewswire\/ — I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Jefferies Global Healthcare Conference on June 5, 2024<\/span>.<\/p>\n

\n<\/div>\n

Jefferies Global Healthcare Conference<\/p>\n

\n

Presentation Time<\/span><\/p>\n

Wednesday, June 5\u00a0at\u00a09:30 a.m. EST<\/span><\/p>\n

Presenters <\/span><\/p>\n

Raj Kannan, CEO; Louie Naumovski, Interim CMO<\/span><\/p>\n

Webcast link<\/span><\/p>\n

Here<\/a><\/span><\/span><\/p>\n

<\/p>\n

Meetings<\/span><\/p>\n

One-on-one and small group meetings:\u00a0June 5, 2024<\/span><\/p>\n

Management
Participants<\/span><\/p>\n

Raj Kannan, CEO<\/span><\/p>\n

Joe Skelton, CFO<\/span><\/p>\n

Louie Naumovski, Interim CMO<\/span><\/p>\n

Tyler Ehler, Senior Director, Investor Relations<\/span><\/p>\n<\/div>\n

The webcast will also be available under “Event Calendar” on\u00a0I-Mab’s\u00a0IR website
at\u00a0https:\/\/ir.i-mabbiopharma.com\/<\/a><\/p>\n

For more information, please contact your Jefferies representative.<\/p>\n

About I-Mab <\/p>\n

I-Mab (NASDAQ: IMAB) is a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland<\/span>, and in San Diego, California<\/span>. For more information, please visit \u00a0https:\/\/ir.i-mabbiopharma.com\/<\/a> and follow us on LinkedIn and X.<\/p>\n

For more information, please contact:
Tyler Ehler<\/span>
Senior Director, Investor Relations
IR@imabbio.com<\/a>\u00a0<\/p>","protected":false},"excerpt":{"rendered":"

<\/p>\n

ROCKVILLE, Md.<\/span><\/span>, May 22, 2024<\/span><\/span> \/PRNewswire\/ — I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Jefferies Global Healthcare Conference on June 5, 2024<\/span>.<\/p>\n

\n<\/div>\n

Jefferies Global Healthcare Conference<\/p>\n

\n

Presentation Time<\/span><\/p>\n

Wednesday, June 5\u00a0at\u00a09:30 a.m. EST<\/span><\/p>\n

Presenters <\/span><\/p>\n

Raj Kannan, CEO; Louie Naumovski, Interim CMO<\/span><\/p>\n

Webcast link<\/span><\/p>\n

Here<\/a><\/span><\/span><\/p>\n<\/p>\n

Meetings<\/span><\/p>\n

One-on-one and small group meetings:\u00a0June 5, 2024<\/span><\/p>\n

Management
Participants<\/span><\/p>\n

Raj Kannan, CEO<\/span><\/p>\n

Joe Skelton, CFO<\/span><\/p>\n

Louie Naumovski, Interim CMO<\/span><\/p>\n

Tyler Ehler, Senior Director, Investor Relations<\/span><\/p>\n<\/div>\n

The webcast will also be available under “Event Calendar” on\u00a0I-Mab’s\u00a0IR website
at\u00a0https:\/\/ir.i-mabbiopharma.com\/<\/a><\/p>\n

For more information, please contact your Jefferies representative.<\/p>\n

About I-Mab <\/p>\n

I-Mab (NASDAQ: IMAB) is a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland<\/span>, and in San Diego, California<\/span>. For more information, please visit \u00a0https:\/\/ir.i-mabbiopharma.com\/<\/a> and follow us on LinkedIn and X.<\/p>\n

For more information, please contact:
Tyler Ehler<\/span>
Senior Director, Investor Relations
IR@imabbio.com<\/a>\u00a0<\/p>\n

<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-2603","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/2603","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2603"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/2603\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2603"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2603"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}